Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 7,621 shares at $15.08 ($115K) on 2022-09-21, disclosed to the SEC on 2022-09-23.
Open-market sale of $115k TRDA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.08 | 3,341 | $50K | 43.8% |
| 2 | $15.08 | 3,341 | $50K | 43.8% |
| 3 | $15.09 | 939 | $14K | 12.3% |
| Total | $15.08 avg | 7,621 | $115K | 100% |
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2023-01-03 | $70K | — | Filing → |